PTH and breast cancer: Our previous systematic review suggested that no significant association between blood 1α,25-(OH)2D level and breast cancer risk [23], which may be due to that 1a,25(OH)2D is under tight regulation by 1a-hydroxylase which is under the control of the parathyroid hormone (PTH) in response to serum calcium.